CN Patent

CN109843858B — 某些化学实体、组合物及方法

Assigned to Neupharma Inc · Expires 2023-05-05 · 3y expired

What this patent protects

本文描述了作为激酶抑制剂的化学实体、药物组合物以及治疗癌症的方法。

USPTO Abstract

本文描述了作为激酶抑制剂的化学实体、药物组合物以及治疗癌症的方法。

Drugs covered by this patent

belumosudil-mesylate (BELUMOSUDIL MESYLATE)

Patent Metadata

Patent number: CN109843858B
Jurisdiction: CN
Classification: —
Expires: 2023-05-05
Drug substance claim: No
Drug product claim: No
Assignee: Neupharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.